Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACCELERON PHARMA INC.

(XLRN)
SummaryQuotesChartsNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Acceleron Pharma Inc.(NasdaqGM:XLRN) dropped from NASDAQ Biotechnology Index

11/22/2021 | 10:30am EST

Acceleron Pharma Inc. has been removed from NASDAQ Biotech Index.


ę S&P Capital IQ 2021
All news about ACCELERON PHARMA INC.
2021GLOBAL MARKETS LIVE : Airbus, BP, Merck, Pfizer, Meta...
2021Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Biotechnology Index
CI
2021ACCELERON PHARMA : Completion of Acquisition or Disposition of Assets - Form 8-K
PU
2021ACCELERON PHARMA INC : Completion of Acquisition or Disposition of Assets, Notice of Delis..
AQ
2021Merck Completes Acceleron Pharma Acquisition
MT
2021Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
AQ
2021Merck Completes Cash Tender Offer to Purchase Acceleron Pharma at $180/Share
MT
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P Biotechnology Select Industry Inde..
CI
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P TMI Index
CI
More news
Analyst Recommendations on ACCELERON PHARMA INC.
More recommendations
Financials (USD)
Sales 2021
Net income 2021
Net Debt 2021
P/E ratio 2021
Yield 2021
Capitalization 10 932 M 10 932 M -
EV / Sales 2021
EV / Sales 2022 52,9x
Nbr of Employees 312
Free-Float 88,0%
Chart ACCELERON PHARMA INC.
Duration : Period :
Acceleron Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Rita A. Karachun President & Director
Kevin F. McLaughlin Chief Financial Officer & Senior Vice President
Ravindra Kumar Chief Scientific Officer & Senior Vice President
Lisa Wyman Vice President-Operations
Kemal Malik Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACCELERON PHARMA INC.39.71%10 932
GILEAD SCIENCES, INC.-7.35%84 382
REGENERON PHARMACEUTICALS-4.16%63 645
VERTEX PHARMACEUTICALS3.93%58 082
WUXI APPTEC CO., LTD.-12.95%47 040
BIONTECH SE-40.05%37 325